Sleep Apnea and Glaucoma: The Eye Pressure Connection No One Talks About

Why ophthalmologists are now asking about your sleep

Glaucoma is the second leading cause of blindness worldwide and the leading cause of irreversible blindness in Europe. For decades it was treated as a problem of intraocular pressure. In 2026, the picture is wider: vascular and oxygen-supply factors matter just as much, and untreated sleep apnea is one of the strongest of those factors. A 2024 meta-analysis in Ophthalmology reported that adults with OSA have roughly 1.7 times the risk of open-angle glaucoma versus matched controls.

If you have been diagnosed with glaucoma — especially the normal-tension form — your sleep is now part of your treatment plan. If you have OSA and have never had an eye check, an annual ophthalmology review is one of the cheapest preventive steps you can add. Our overview of understanding sleep apnea explains the basics; this article focuses on the eye pressure connection.

How sleep apnea damages the optic nerve

The optic nerve is metabolically demanding and highly oxygen-sensitive. Three OSA-driven mechanisms compromise its blood and oxygen supply.

1. Intermittent hypoxia

Each apnea drops oxygen saturation. Repeated dips reduce optic nerve oxygenation, increasing oxidative stress in retinal ganglion cells. Over years, this accelerates the cell loss that defines glaucoma.

2. Vascular dysregulation

OSA promotes endothelial dysfunction. The optic nerve relies on tight microcirculation control; lose that and pressure variations cause damage that a healthy nerve would absorb.

3. Intraocular pressure swings

Apnea-driven sympathetic surges raise blood pressure and intraocular pressure simultaneously. A 2023 paper in the British Journal of Ophthalmology using continuous overnight IOP monitoring found average rises of 2 to 4 mmHg in OSA patients during respiratory events. These swings, not just absolute pressure, damage the optic nerve.

Which glaucoma types are most linked to OSA

If you have normal-tension glaucoma and have never been screened for OSA, ask your ophthalmologist or GP. Several European guidelines now flag this combination explicitly.

What CPAP and other OSA therapies do for the eye

The evidence base on CPAP for glaucoma is still maturing. What we have so far is encouraging.

CPAP and intraocular pressure

A 2022 randomised study in the European Journal of Ophthalmology showed that CPAP used at least four hours per night for six months reduced overnight IOP variability by 30% in OSA patients with mild glaucoma. Daytime mean IOP changed less, but the overnight smoothing is the key clinical signal.

CPAP and visual field progression

Long-term cohorts in Spain and France (2023–2024) show slower visual field loss in glaucoma patients who became adherent to CPAP versus those who refused. The effect is not as large as topical hypotensive drops, but it is additive.

What about positive pressure on the eye itself?

Older case reports raised concern that CPAP mask pressure could transiently raise IOP. Current evidence shows the systemic respiratory benefit clearly outweighs this small mechanical effect in standard CPAP use. Modern minimal-contact masks reduce the issue.

Mandibular advancement devices, nasal stents, surgery

Direct trials in glaucoma are limited. By analogy, any therapy that meaningfully reduces AHI and overnight desaturations should benefit the optic nerve. For mild OSA, the Back2Sleep nasal stent is a reasonable option that improves nasal breathing and reduces snoring without a mask.

Practical screening and management plan for 2026

If you have glaucoma but no OSA diagnosis

• Discuss sleep apnea screening at your next ophthalmology review.
• Track snoring, daytime sleepiness, and partner-witnessed apneas.
• Take our sleep risk screening for a quick estimate.
• Ask for a home sleep test if two or more risk factors apply.

If you have OSA but no glaucoma diagnosis

• Add an annual ophthalmology check, with optic disc imaging.
• Use treatment adherence as the strongest preventive lever — a treated airway protects the optic nerve.
• Read our broader explainer on sleep apnea and blood pressure — vascular health is the common ground.

If you have both

• Stay adherent to your topical medication or laser treatment as prescribed.
• Treat OSA effectively — CPAP first if moderate or severe; nasal stent or MAD if mild and CPAP refused.
• Avoid sleeping flat on your back where possible — supine sleep raises IOP further.
• Consider 24-hour IOP curve testing if visual field continues to progress.

Other eye conditions linked to sleep apnea

Glaucoma is the most studied OSA-eye link, but it is not the only one. Three other conditions show consistent associations.

Non-arteritic anterior ischemic optic neuropathy (NAION)

NAION is sudden vision loss caused by reduced blood flow to the optic nerve head, often noticed on waking. It is up to four times more common in OSA patients than in matched controls. Effective OSA treatment may reduce the recurrence risk in the second eye.

Diabetic retinopathy progression

Diabetic patients with severe OSA progress to proliferative retinopathy 2.5 times faster than those without OSA. Treating OSA slows the rate of progression even when diabetes control is similar.

Central serous chorioretinopathy

This poorly-understood retinal condition appears more often in OSA patients, especially men aged 30–50. The mechanism is suspected to involve sympathetic activation and steroid-like effects of cortisol disruption.

Dry eye and ocular surface disease

CPAP mask leak can blow air over the eyes overnight, drying the cornea. The fix is mask refitting or eye protection, not stopping CPAP. Floppy eyelid syndrome (closely linked to OSA) also drives chronic ocular surface inflammation.

What ophthalmologists examine when OSA is suspected

European glaucoma services in 2026 increasingly run a short OSA screening at first visit. Most use the STOP-Bang questionnaire, which combines snoring, tiredness, observed apnea, blood pressure, BMI, age, neck circumference, and gender. A score of three or more triggers a referral for a sleep study.

Tests that matter

• Visual field perimetry — detects early functional loss before the patient notices.
• Optical coherence tomography (OCT) — measures the retinal nerve fibre layer thickness, often thinner in OSA patients than in matched controls.
• 24-hour IOP curve — reveals nocturnal pressure spikes invisible to daytime measurement.
• Disc photography — baseline for progression.

A 2024 Italian cohort showed retinal nerve fibre layer thinning was 18% greater in untreated severe OSA than in mild OSA, regardless of daytime IOP. The finding strengthens the case for treating moderate-severe OSA even when glaucoma is "well controlled".

Lifestyle steps that protect both eye pressure and sleep breathing

Several habits help both conditions at once. None require a prescription.

• Side-sleep with head elevation — lowers supine IOP and reduces airway collapse.
• Hydration but not before bed — drinking large volumes 90 minutes before sleep can spike IOP overnight.
• Limit alcohol — alcohol raises IOP transiently and worsens OSA via muscle relaxation.
• Quit smoking — smoking accelerates glaucoma progression and worsens OSA risk.
• Aerobic exercise — 150 minutes per week reduces both IOP and OSA severity in randomised trials.
• Weight management — a 5–10% loss helps both conditions, especially in obese patients.